Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 2, 2011-03 ,pp. : 215-234

Bentham Science Publishers

Access to resources Recommend Favorite

What can be done to improve patient safety in phase I trials?

By  

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Protecting and using patient information: the role of the Caldicott Guardian

By Greenough Anne   Graham Helen  

Clinical Medicine, Vol. 4, Iss. 3, 2004-05 ,pp. : 246-249

Royal College Of Physicians

Access to resources Recommend Favorite

Enhancing Trial Integrity by Protecting the Independence of Data Monitoring Committees in Clinical Trials

By        

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 968-975

Taylor & Francis Ltd

Access to resources Recommend Favorite

Patient safety not on FDA's agenda

By  

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite